ArticleFrontiers in pharmacology2018

Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma.

Xingliang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.